A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/09/2011	CN101597290B Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
11/09/2011	CN101591375B Compound with analgesic activity, preparation method and application thereof
11/09/2011	CN101584703B Pharmaceutical composition for treating colpitis and preparation method thereof
11/09/2011	CN101579329B Bevantolol hydrochloride sustained release preparation
11/09/2011	CN101569618B Application of long-chain fatty acid derivative or plant extracts containing same in inhibiting the activity of aromatizing enzyme
11/09/2011	CN101544953B Oxytropis Ehrig cinerea FEL2-OG and separation method and application thereof
11/09/2011	CN101508720B Triterpene extracts of achyranthes bidentata and uses in osteosporosis resistant medicament
11/09/2011	CN101502510B Medicament composition for treating colpitis symptoms and preparation method thereof
11/09/2011	CN101502503B Application of fluorobenzene salicylamide compound in preparing anti-tumor medicament
11/09/2011	CN101497608B HIV protease inhibitor derivative, preparation thereof and use in antineoplastic medicament preparation
11/09/2011	CN101474375B Compound Cordyceps militaris L. Link preparation and production method and application
11/09/2011	CN101454296B Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/09/2011	CN101443332B Anti-viral pyrimidine nucleoside derivatives
11/09/2011	CN101443012B Azoxystrobin formulations
11/09/2011	CN101422450B Cajanus cajan L. natural medicine with blood sugar reduction and weight reduction function
11/09/2011	CN101420982B Dry direct compression fast disintegrating tablet
11/09/2011	CN101406680B Compound syrup paste for epilepsy
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101396560B Medicine composition for treating polycystic kidney disease and use thereof
11/09/2011	CN101390844B Arginine ibuprofen tablet and preparation method thereof
11/09/2011	CN101371842B Lornoxicam microsphere and preparation method thereof
11/09/2011	CN101365449B Nanoparticulate benzothiophene formulations
11/09/2011	CN101352497B Chinese medicinal composition for removing chloasma, and preparation method and uses thereof
11/09/2011	CN101346390B Water-soluble benzoazepine compound and its pharmaceutical composition
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101301417B Powder for treating circumscribed external otitis
11/09/2011	CN101300231B Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
11/09/2011	CN101278932B Sustained release medicinal compositions containing Zaltoprofen, preparation method and application thereof
11/09/2011	CN101273040B Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists
11/09/2011	CN101269087B Pectin-5-efudix colon cancer double-target prodrug and preparation method
11/09/2011	CN101265281B Method for preparing dithioamnoformic acid modifying glucose chelating agent
11/09/2011	CN101264096B Use of ginsenoside Rg1 in preparing spermatogenic product
11/09/2011	CN101253155B 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
11/09/2011	CN101204537B Chinese traditional medicine composite for reducing spitting, dispelling wind, and relieving convulsion and preparation method thereof
11/09/2011	CN101204196B Feed soybean oligosaccharide powder and manufacture method thereof
11/09/2011	CN101161245B Purpose of toluylene glycosides and its derivant for restraining synapse ribonucleoprtein excess expression
11/09/2011	CN101143145B Tadalafil chewing gum and manufacturing method and application
11/09/2011	CN101076316B Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity
11/09/2011	CN101048402B Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/09/2011	CN101039698B Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation
11/09/2011	CN101032683B Xanthin micro-capsule and the preparing method
11/08/2011	USRE42902 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
11/08/2011	US8053603 Tetralone-based monoamine reuptake inhibitors
11/08/2011	US8053599 Drug containing (2R)-2-propyloctanoic acid as the active ingredient
11/08/2011	US8053598 Compounds, their preparation and use
11/08/2011	US8053583 Anti-cancer compound and manufacturing method thereof
11/08/2011	US8053581 Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof
11/08/2011	US8053577 Derivatives of 5,9-methanocycloocta[b]pyridin-2-(1H)-one, their preparation and use as analgesics
11/08/2011	US8053576 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene
11/08/2011	US8053574 Organic compounds
11/08/2011	US8053573 Monomer 5, 6-diphenyl-1.2.4-traizinic derivatives and the use thereof
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053477 Including but hot limited to pentamidine and derivatives thereof
11/08/2011	US8053476 Method for treating peripheral neuropathic pain
11/08/2011	US8053475 Preparation of the formaurindikarboxyl acid base and its derivations and use
11/08/2011	US8053474 Compound with carboxyl acid group and amide group and application thereof
11/08/2011	US8053473 Antibacterial agent comprising 7, 10-dihydroxy-8(E)-octadecenoic acid
11/08/2011	US8053472 Quantity of acetyl L-carnitine to be administered is 0.1 to 2 g/day, while the dose of biotin is 1 to 8 mg/day
11/08/2011	US8053471 Nutrition containing fat blend
11/08/2011	US8053470 Process for the preparation of polynuclear ferric hydroxide-saccaride complexes
11/08/2011	US8053469 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions
11/08/2011	US8053468 Glycerol levulinate ketals and their use
11/08/2011	US8053467 Flavor improving agent, and food and drink containing the same
11/08/2011	US8053466 Oxathiane derivative as perfuming ingredient
11/08/2011	US8053465 Bicycloester derivative
11/08/2011	US8053463 e.g. {3-butoxy-5-[4-(4-trifluoromethoxy-phenoxy)-benzenesulfonyl]-phenyl}-acetic acid; peroxisome proliferator activated receptor modulator; antidiabetic agent; obesity, hyperlipidemia, dyslipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema
11/08/2011	US8053462 Indole derivative and application thereof
11/08/2011	US8053461 Oxindole derivative
11/08/2011	US8053460 Chemoosensitizer for dug resistance tumors
11/08/2011	US8053459 Selenolopyrazole derivatives and use thereof as anticancer agents
11/08/2011	US8053458 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example
11/08/2011	US8053457 3-imidazolyl-indoles for the treatment of proliferative diseases
11/08/2011	US8053456 Triazole compounds that modulate Hsp90 activity
11/08/2011	US8053455 Angiotensin II receptor antagonists
11/08/2011	US8053454 Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
11/08/2011	US8053453 Pyrazolone compounds and thrombopoietin receptor activator
11/08/2011	US8053451 Hydroxybenzoate salts of metanicotine compounds
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	US8053449 Method for inhibiting AGE complex formation
11/08/2011	US8053448 Biphenyl compounds useful as muscarinic receptor antagonists
11/08/2011	US8053447 11β-hydroxysteroid dehydrogenase type 1 active compounds
11/08/2011	US8053446 Cyanoguanidine compounds
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	US8053444 Pharmaceutical polymer and fatty acid ester stabilized amorphous oral solid dosage form with enhanced dissolution properties
11/08/2011	US8053443 N-substituted indenoisoquinolines and syntheses thereof
11/08/2011	US8053442 Organic compounds
11/08/2011	US8053441 Pyrazolylquinazolinones as potassium channel openers
11/08/2011	US8053440 To regulate the expression of apolipoprotein A-I; atherosclerosis; improved pharmacological properties; 3-(4-hydroxy-3,5-dimethylphenyl)-6,8-dimethoxyisoquinolin-1(2H)-one; to reduce cholesterol levels; agonists
11/08/2011	US8053439 Benzophenone derivatives useful for inhibiting formation of microtubule
11/08/2011	US8053438 Pyrazine compounds as phosphodiesterase 10 inhibitors
11/08/2011	US8053437 Furo[3. 2-B] pyrrol derivatives
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	US8053435 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
11/08/2011	US8053434 Kinase inhibitors and their uses
11/08/2011	US8053433 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
11/08/2011	US8053432 Cyclic hydroxylamine as psychoactive compounds
11/08/2011	US8053431 Pharmaceutical use of substituted amides
11/08/2011	US8053430 Treatment of renal cell carcinoma
11/08/2011	US8053428 Vinorelbine derivatives
11/08/2011	US8053427 Brimonidine gel composition

1 ... 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 ... 7860